Skip to main content
Premium Trial:

Request an Annual Quote

Guardant Health to License IP to Foundation Medicine for $25M, Royalties Under Settlement Agreement

This article has been updated from a previous version to include additional information provided by Guardant Health.

NEW YORK – Guardant Health will nonexclusively license its digital sequencing technology patents to Roche subsidiary Foundation Medicine for $25 million plus royalties on future sales of Foundation's liquid biopsy products, settling patent lawsuits filed by Guardant against Foundation.

In a May 17 filing with the US Securities and Exchange Commission, Guardant said that the license deal is part of a binding term sheet signed on May 13, which states that upon execution of a definitive settlement agreement between the two firms, all pending patent litigation between the parties will be dismissed.

Foundation Medicine will pay Guardant $25 million as well as certain royalties for the remaining term of the patents in exchange for its nonexclusive license.

A hearing over allegations that Guardant CEO Helmy Eltoukhy had improperly deleted emails relevant to Foundation Medicine's defense had been scheduled for May 13. In addition, a hearing to decide on a preliminary injunction to stop the sale of the FoundationOne CDx liquid biopsy product had been scheduled for May 14. The judge ordered at that time that pursuant to the companies' agreement, various associated motions were being withdrawn.

The Scan

Another Resignation

According to the Wall Street Journal, a third advisory panel member has resigned following the US Food and Drug Administration's approval of an Alzheimer's disease drug.

Novavax Finds Its Vaccine Effective

Reuters reports Novavax's SARS-CoV-2 vaccine is more than 90 percent effective in preventing COVID-19.

Can't Be Used

The US Food and Drug Administration says millions of vaccine doses made at an embattled manufacturing facility cannot be used, the New York Times reports.

PLOS Papers on Frozen Shoulder GWAS, Epstein-Barr Effects on Immune Cell Epigenetics, More

In PLOS this week: genome-wide association study of frozen shoulder, epigenetic patterns of Epstein-Barr-infected B lymphocyte cells, and more.